115 related articles for article (PubMed ID: 38149454)
21. Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.
Martinez-Quintanilla J; He D; Wakimoto H; Alemany R; Shah K
Mol Ther; 2015 Jan; 23(1):108-18. PubMed ID: 25352242
[TBL] [Abstract][Full Text] [Related]
22. The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.
Klawitter M; El-Ayoubi A; Buch J; Rüttinger J; Ehrenfeld M; Lichtenegger E; Krüger MA; Mantwill K; Koll FJ; Kowarik MC; Holm PS; Naumann U
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077380
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
Jiang G; Sun C; Li RH; Wei ZP; Zheng JN; Liu YQ
J Cancer Res Clin Oncol; 2015 Jan; 141(1):75-85. PubMed ID: 25103017
[TBL] [Abstract][Full Text] [Related]
24. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
25. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
[No Abstract] [Full Text] [Related]
26. Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.
Seliger C; Meyer AL; Renner K; Leidgens V; Moeckel S; Jachnik B; Dettmer K; Tischler U; Gerthofer V; Rauer L; Uhl M; Proescholdt M; Bogdahn U; Riemenschneider MJ; Oefner PJ; Kreutz M; Vollmann-Zwerenz A; Hau P
Cell Cycle; 2016 Jul; 15(13):1755-66. PubMed ID: 27163626
[TBL] [Abstract][Full Text] [Related]
27. Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.
Passaro C; Alayo Q; De Laura I; McNulty J; Grauwet K; Ito H; Bhaskaran V; Mineo M; Lawler SE; Shah K; Speranza MC; Goins W; McLaughlin E; Fernandez S; Reardon DA; Freeman GJ; Chiocca EA; Nakashima H
Clin Cancer Res; 2019 Jan; 25(1):290-299. PubMed ID: 30279232
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell Carcinoma.
Zhang W; Zhang C; Tian W; Qin J; Chen J; Zhang Q; Fang L; Zheng J
Hum Gene Ther; 2020 Jun; 31(11-12):651-663. PubMed ID: 32216478
[TBL] [Abstract][Full Text] [Related]
29. Engineering Adenoviral Vectors with Improved GBM Selectivity.
Bates EA; Lovatt C; Plein AR; Davies JA; Siebzehnrubl FA; Parker AL
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243172
[TBL] [Abstract][Full Text] [Related]
30. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
Oh E; Choi IK; Hong J; Yun CO
Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
[TBL] [Abstract][Full Text] [Related]
31. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
[TBL] [Abstract][Full Text] [Related]
33. Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.
Jiang G; Yang CS; Xu D; Sun C; Zheng JN; Lei TC; Liu YQ
Br J Cancer; 2014 May; 110(10):2496-505. PubMed ID: 24714752
[TBL] [Abstract][Full Text] [Related]
34. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
Phillips LM; Li S; Gumin J; Daou M; Ledbetter D; Yang J; Singh S; Parker Kerrigan BC; Hossain A; Yuan Y; Gomez-Manzano C; Fueyo J; Lang FF
Neuro Oncol; 2021 Nov; 23(11):1911-1921. PubMed ID: 34059921
[TBL] [Abstract][Full Text] [Related]
35. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
[TBL] [Abstract][Full Text] [Related]
36. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
Hamed HA; Yacoub A; Park MA; Archer K; Das SK; Sarkar D; Grant S; Fisher PB; Dent P
Mol Pharmacol; 2013 Aug; 84(2):171-81. PubMed ID: 23661648
[TBL] [Abstract][Full Text] [Related]
38. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.
Tobias AL; Thaci B; Auffinger B; Rincón E; Balyasnikova IV; Kim CK; Han Y; Zhang L; Aboody KS; Ahmed AU; Lesniak MS
Stem Cells Transl Med; 2013 Sep; 2(9):655-66. PubMed ID: 23926209
[TBL] [Abstract][Full Text] [Related]
39. Biological Role and Therapeutic Targeting of TGF-β
Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
[TBL] [Abstract][Full Text] [Related]
40. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]